(Q37871313)

24 August 2017

A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma (English)

1 reference

24 August 2017

Chlamydia trachomatis

0 references

7

Göran Hallmans

1 reference

24 August 2017

13

Joakim Dillner

1 reference

24 August 2017

12

Jorma Paavonen

1 reference

24 August 2017

Keng-Ling Wallin

1

1 reference

24 August 2017

Fredrik Wiklund

2

1 reference

24 August 2017

Tapio Luostarinen

3

1 reference

24 August 2017

Tord Angström

4

1 reference

24 August 2017

Tarja Anttila

5

1 reference

24 August 2017

Frank Bergman

6

1 reference

24 August 2017

Irma Ikäheimo

8

1 reference

24 August 2017

Pentti Koskela

9

1 reference

24 August 2017

Matti Lehtinen

10

1 reference

24 August 2017

Ulf Stendahl

11

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

International Journal of Cancer

24 August 2017

1 reference

24 August 2017

101

1 reference

24 August 2017

4

1 reference

24 August 2017

371-374

1 reference

Estimates of the worldwide mortality from 25 cancers in 1990.

24 August 2017

1 reference

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

21 January 2018

1 reference

The epidemiology of cervical carcinogenesis

21 January 2018

1 reference

Chlamydia trachomatis: impact on human reproduction

21 January 2018

1 reference

The frequency of salpingitis and ectopic pregnancy as epidemiologic markers of Chlamydia trachomatis

21 January 2018

1 reference

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

21 January 2018

1 reference

Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up

21 January 2018

1 reference

Sexually transmitted agents and cervical neoplasia in Colombia and Spain

21 January 2018

1 reference

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma

21 January 2018

1 reference

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

21 January 2018

1 reference

Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma

21 January 2018

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

Chlamydial cervicitis and cervical intraepithelial neoplasia: an immunohistochemical analysis

21 January 2018

1 reference

Cytologic manifestations of cervical and vaginal infections. II. Confirmation of Chlamydia trachomatis infection by direct immunofluorescence using monoclonal antibodies

21 January 2018

1 reference

Detection of Chlamydia trachomatis DNA in cervical samples with regard to infection by human papillomavirus

21 January 2018

1 reference

High prevalence of chlamydia and Pap-smear abnormalities in pregnant adolescents warrants routine screening

21 January 2018

1 reference

Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation

21 January 2018

1 reference

Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals

21 January 2018

1 reference

IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection

21 January 2018

1 reference

Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10639

1 reference

24 August 2017

1 reference